Tadalafil 10 - Androlex

Initially designated IC351, tadalafil citrate was developed by ICOS and later commercialized with Eli Lilly as Cialis. It quickly gained recognition for its prolonged effect—lasting up to 36 hours—making it the longest-acting PDE5 inhibitor. Its molecular structure differs from other drugs in its class, enhancing selectivity for PDE5 and reducing side effects like vision changes. Approved in 2003, it soon became a preferred treatment for men seeking both efficacy and the freedom from time-restricted dosing.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tadalafil 10 by Androlex, consult with your doctor or healthcare professional.